seed
Stage
2020
Founded
1
Investors
About
toll-like receptor 7 agonists as immunotherapies
Explore Primmune Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
toll-like receptor 7 agonists as immunotherapies
Funding rounds, investor list, and risk signals — unlock with a subscription.